Yuichi Shinozaki
Asahikawa Medical University(JP)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Liver Disease Diagnosis and Treatment, Diabetes Treatment and Management, Chronic Kidney Disease and Diabetes, Dermatology and Skin Diseases
Most-Cited Works
- → Sodium–glucose cotransporters: Functional properties and pharmaceutical potential(2020)149 cited
- → Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo(2014)100 cited
- → A novelJAKinhibitorJTE‐052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents(2017)60 cited
- → Ferric Citrate Hydrate, a New Phosphate Binder, Prevents the Complications of Secondary Hyperparathyroidism and Vascular Calcification(2013)54 cited
- → Discovery of (1S,2R,3R)-2,3-Dimethyl-2-phenyl-1-sulfamidocyclopropanecarboxylates: Novel and Highly Selective Aggrecanase Inhibitors(2011)49 cited
- → JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor(2019)43 cited
- → JTZ-951, an HIF prolyl hydroxylase inhibitor, suppresses renal interstitial fibroblast transformation and expression of fibrosis-related factors(2019)20 cited
- → Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitors(2009)19 cited
- → Novel N-substituted 2-phenyl-1-sulfonylamino-cyclopropane carboxylates as selective ADAMTS-5 (Aggrecanase-2) inhibitors(2009)17 cited
- → Stereochemistry of mono- and dinuclear complexes of rhodium, iridium and ruthenium bearing bis(diphenylphosphinomethyl)phenylphosphine(2003)15 cited